ArticleFrontiers in oncology2021

Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma.

Jingjun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.